Relationship between Factor VIII Mutation Type and Inhibitor Development in a Cohort of Previously Untreated Patients Treated with Recombinant Factor VIII (Recombinate™)

Summary

A cohort of 79 previously untreated patients (PUPs) with moderatesevere haemophilia A (baseline Factor VIII <2%) were enrolled in a study to evaluate the safety, efficacy and immunogenicity of recombinant factor VIII (r-FVIII, Recombinate™). Blood samples were obtained retrospectively from a total 55 PUPs who were investigated for the spectrum of FVIII gene mutations responsible for their haemophilia. FVIII gene inversion mutations were found in 27 (49%) patients. Two patients had partial gene deletions. The remaining 26 patients were then screened for mutations in the FVIII gene coding region using conformation sensitive gel electrophoresis. Point mutations were identified in 22 (85%) of the patients and 14 of these mutations were novel. Study subjects were monitored for the development of FVIII inhibitors throughout the study. A total of 23 of the 73 evaluable subjects (including one subject with a low inhibitor titer at baseline) demonstrated an inhibitor on one or more occasions; 11 (15%) were persistent. Inhibitors were detected in patients with partial gene deletions and inversions and in three of eight patients with missense mutations. No inhibitors were found in 11 patients with small insertions or deletions resulting in an alteration of the protein translation reading frame (frameshift mutations). The results corroborate the observation that mutation type is an important determinant of the propensity to develop inhibitory anti-FVIII antibody.

Keywords

Haemophilia A - factor VIII gene - inhibitor - mutation - FVIII inversion

• References

• 1 Rosendaal FR, Nieuwenhuis HK, van den Berg HM, Heijboer H, Mauser-Bunschoten EP, van der Meer J, Smit C, Strengers PF, Briet E. A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Blood 1993; 81: 2180-6.
• 2 Hay CRM, Ollier W, Pepper L, Cumming A, Keeney S, Goodeve AC, Colvin BT, Hill FGH, Preston FE, Peake IR. HLA class II profile: A weak determinant of factor VIII inhibitor development in severe haemophilia A. Thromb Haemost 1997; 77: 234-7.
• 3 Oldenburg J, Picard JK, Schwaab R, Brackmann HH, Tuddenham EGD, Simpson E. HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII. Thromb Haemost 1997; 77: 238-42.
• 4 Schwaab R, Brackmann HH, Meyer C, Seehafer J, Kirchgesser M, Haack A, Olek K, Tuddenham EGD, Oldenburg J. Haemophilia A: mutation type determines risk of inhibitor formation. Thromb Haemost 1995; 74: 1402-6.
• 5 Kasper CK, Aledort LM, Counts RB, Edson JR, Frantatoni J, Green D, Hampton JW, Hilgardner MW, Lazerson J, Levine PH, McMillan CW, Pool JG, Shapiro SS, Shulman NR, von Eys J. A more uniform measurement of factor VIII inhibitors. Thrombos Diasthes Haemorrh 1975; 34: 869-72.
• 6 Goodeve AC, Preston FE, Peake IR. Factor VIII gene rearrangements in severe haemophilia A. Lancet 1994; 343: 329-30.
• 7 Williams IJ, Abuzenadah A, Winship PR, Preston FE, Dolan G, Wright J, Peake IR, Goodeve AC. Precise carrier diagnosis in families with haemophilia A: Use of conformation sensitive gel electrophoresis for mutation screening and polymorphism analysis. Thromb Haemost 1998; 79: 723-6.
• 8 Young M, Inaba H, Hoyer LW, Higuchi M, Kazazian HH, Antonarakis SE. Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene. Am J Hum Genet 1997; 60: 565-73.
• 9 Oldenburg J, Schroder J, Schmitt C, Brackmann HH, Schwaab R. Small deletion/insertion mutations within poly-A runs of the factor VIII gene mitigate the severe haemophilia A phenotype. Thromb Haemost 1998; 79: 452-3.
• 10 Inaba H, Takahashi I, Suzuki T, Nagaizumi K, Arai M, Fukutake K. Frameshift mutations within poly-A sequence within exon 14 of factor VIII gene escape from severe haemophilia A phenotype. Thromb Haemost. 1999 Suppl.; 880..
• 11 KemballCook G, Tuddenham EGD, Wacey AI. The factor VIII structure and mutation resource site: HAMSTeRS version 4. Nucleic Acids Res 1998; 26: 216-9 http://europium.csc.mrc.ac.uk
• 12 Fujimura FK, Buzin C, Wen CY, Nguyen VQ, Nozari G, Mengos A, Li X, Li W, Liu J, Crawford L, Liu Q, Sommer SS. Molecular analysis of hemophilia A families: Direct detection of virtually all factor VIII gene mutations in regions of likely functional significance. Thromb Haemost. 1999 Suppl.: 2496.
• 13 Naylor JA, Green PM, Rizza CR, Giannelli F. Analysis of factor-VIII messenger-RNA reveals defects in everyone of 28 hemophilia-A patients. Hum Mol Genet 1993; 02: 11-7.
• 14 Waseem NH, Bagnall R, Green PM, Giannelli F. Start of UK confidential haemophilia A database: analysis of 142 patients by solid phase fluorescent chemical cleavage of mismatch. Thromb Haemost 1999; 81: 900-5.
• 15 Attali O, Vinciguerra C, Trzeciak MC, Durin A, Pernod G, Gay V, Menart C, Sobas F, Dechavanne M, Negrier C. Factor IX gene analysis in 70 unrelated patients with haemophilia B: Description of 13 new mutations. Thromb Haemost 1999; 82: 1437-42.
• 16 Hinks J, Winship PR, Makris M, Preston FE, Peake IR, Goodeve AC. Conformation sensitive gel electrophoresis for precise haemophilia B carrier analysis. Br J Haematol 1999; 104: 915-8.
• 17 Feng JN, Liu Q, Drost J, Sommer SS. Deep intronic mutations are rarely a cause of hemophilia B. Hum Mutation 1999; 14: 267-8.
• 18 Antonarakis SE, Rossiter JP, Young M, Horst J, Demoerloose P, Sommer SS, Ketterling RP, Kazazian HH, Negrier C, Vinciguerra C, Gitschier J, Goossens M, Girodon E, Ghanem N, Plassa F, Lavergne JM, Vidaud M, Costa JM, Laurian Y, Lin SW, Lin SR, Shen MC, Lillicrap D, Taylor SAM, Windsor S, Valleix SV, Nafa K, Sultan Y, Delpech M, Vnencakjones CL, Phillips JA, Ljung RCR, Koumbarelis E, Gialeraki A, Mandalaki T, Jenkins PV, Collins PW, Pasi KJ, Goodeve A, Peake I, Preston FE, Schwartz M, Scheibel E, Ingerslev J, Cooper DN, Millar DS, Kakkar VV, Giannelli F, Naylor JA, Tizzano EF, Baiget M, Domenech M, Altisent C, Tusell J, Beneyto M, Lorenzo JI, Gaucher C, Mazurier C, Peerlinck K, Matthijs G, Cassiman JJ, Vermylen J, Mori PG, Acquila M, Caprino D, Inaba H. Factor-VIII gene inversions in severe hemophilia-A – results of an international consortium study. Blood 1995; 86: 2206-12.